Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.

A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.

The American Gastroentero-logical Association (AGA) has honored Pelayo Correa, M.D., with its Distinguished Achievement Award, which recognizes an individual for contributions to research that have advanced the science and practice of gastroenterology.

Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.

The 50th anniversary of the Division of Clinical Pharmacology will be celebrated Thursday, June 6, with a daylong scientific symposium and luncheon in the Student Life Center.

For 30 minutes Tuesday, Terry Marlin, father of two young boys with Duchenne muscular dystrophy, was the professor, telling his story to a group of Vanderbilt University graduate students and postdoctoral fellows.